Search filters

List of works by Paweł Kawalec

A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis

scientific article published on 19 December 2017

A comment on Craig et al.: ''Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization: a NICE single technology appraisal''.

scientific article published in June 2013

A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction

scientific article published in January 2006

A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction

scientific article published in December 2006

An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis

scientific article

An indirect comparison of ustekinumab and vedolizumab in the therapy of TNF-failure Crohn's disease patients

scientific article published on 8 November 2017

Associations of Nutritional Behavior and Gut Microbiota with the Risk of COVID-19 in Healthy Young Adults in Poland

scientific article published on 14 January 2022

Clinical efficacy and safety of prolonged use of the valganciclovir for the treatment of cytomegalovirus disease in patients after kidney transplantation

scientific article

Coffee consumption and colorectal cancer risk: a dose-response meta-analysis on prospective cohort studies

scientific article published on 28 March 2019

Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries

article

Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland

scientific article

Cost-Effectiveness Analysis of Crohn's Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumor Necrosis Factor-α Antagonist.

scientific article published on 17 April 2018

Cost-Utility Analysis of Infliximab with Standard Care versus Standard Care Alone for Induction and Maintenance Treatment of Patients with Ulcerative Colitis in Poland

scientific article

Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project

scientific article published on 01 January 2013

Cost-effectiveness of biological treatment of ulcerative colitis - a systematic review

scientific article

Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland

scientific article published on 06 August 2016

Cost-utility analysis of Ruconest(®) (conestat alfa) compared to Berinert(®) P (human C1 esterase inhibitor) in the treatment of acute, life-threatening angioedema attacks in patients with hereditary angioedema

scientific article published on 20 June 2013

Cultural adaptation of the Safety Attitudes Questionnaire - Short Form (SAQ-SF) in Poland

scientific article published in 2021

Developments in the discovery and design of intranasal antidepressants

scientific article published on 21 June 2020

Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland.

scientific article published on 23 June 2016

Disease activity, quality of life and indirect costs of reduced productivity at work, generated by Polish patients with ankylosing spondylitis

scientific article published on January 2015

Disease activity, quality of life, and indirect costs of ulcerative colitis in Poland

scientific article published on 07 March 2017

Drug Policies in Central and Eastern European Countries

scientific article published on 12 September 2017

Drug Policy in Bulgaria.

scientific article published on 9 September 2017

Drug Policy in Poland

scientific article published on September 2017

Economic evaluation of single-pill combination of indapamide and amlodipine in the treatment of arterial hypertension in the Polish setting.

scientific article published on 19 May 2015

Economic evaluation of sipuleucel-T immunotherapy in castration-resistant prostate cancer.

scientific article published on January 2014

Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

scientific article

Effectiveness and safety of vedolizumab for treatment of Crohn's disease: a systematic review and meta-analysis

scientific article

Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis

article

Effectiveness of targeted therapy as monotherapy or combined therapy in patients with relapsed or refractory multiple myeloma: a systematic review and meta-analysis

scientific article

Effectiveness of targeted therapy in patients with previously untreated metastatic breast cancer: a systematic review and meta-analysis

scientific article

Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder

scientific article published on 30 October 2019

Efficacy and safety of ustekinumab in the induction therapy of TNF-α-refractory Crohn's disease patients: a systematic review and meta-analysis

scientific article

Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials

scientific article published on 16 April 2020

European perspective on the management of rheumatoid arthritis: clinical utility of tofacitinib

scientific article published on 21 December 2017

Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

scientific article published on 08 October 2020

Health technology assessment of medical devices

scientific article published in 2018

Health utility of patients with Crohn's disease and ulcerative colitis: a systematic review and meta-analysis

scientific article published on 17 May 2016

Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland

scientific article

Impact of Biologic Treatment of Crohn's Disease on the Rate of Surgeries and Other Healthcare Resources: An Analysis of a Nationwide Database From Poland.

scientific article published on 11 June 2018

Impact of patient outcomes and cost aspects on reimbursement recommendations in Poland in 2012-2014.

scientific article published on 26 October 2016

Implementation of the 2011 Reimbursement Act in Poland: Desired and undesired effects of the changes in reimbursement policy.

scientific article published on 8 March 2016

Indirect costs of inflammatory bowel diseases: Crohn's disease and ulcerative colitis. A systematic review

scientific article

Indirect health costs in ulcerative colitis and Crohn's disease: a systematic review and meta-analysis.

scientific article published on 06 February 2015

Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid carcinoma: a systematic review and indirect comparison with sorafenib.

scientific article

Nevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trials

scientific article

New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib

scientific article published on 13 February 2019

Nutrition Behaviors in Polish Adults before and during COVID-19 Lockdown

scientific article published on 10 October 2020

Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review.

scientific article published on 18 December 2017

Pharmaceutical regulation in 15 European countries review

scientific article published on October 2016

Potential Cost-Savings From the Use of the Biosimilars in Slovakia

scientific article published on 21 August 2020

Pregabalin for the treatment of social anxiety disorder

scientific article published on 31 October 2014

Prevalence and drug treatment practices of inflammatory bowel diseases in Poland in the years 2012-2014: an analysis of nationwide databases.

scientific article published on 18 December 2017

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries

scientific article

Productivity Loss Among Parents of Children with Inflammatory Bowel Diseases in Relation to Disease Activity and Patient's Quality of Life

scientific article published on 26 May 2020

Pseudomeningeal syndrome of Dupre associated with cervical discopathy--case report

scientific article published on 28 April 2009

Quality of life related to oral, subcutaneous, and intravenous biologic treatment of inflammatory bowel disease: a time trade-off study

scientific article published on 29 November 2017

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries

scientific article published on 08 May 2019

Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries

scientific article published on 27 November 2019

Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment

article

Relating Health Technology Assessment recommendations and reimbursement decisions in Poland in years 2012-2014, a retrospective analysis.

scientific article published on 11 October 2016

Relationship between physician-based assessment of disease activity, quality of life, and costs of ulcerative colitis in Poland.

scientific article

Safety Profile of Biologic Drugs in the Therapy of Ulcerative Colitis: A Systematic Review and Network Meta-Analysis

scientific article published on 17 June 2016

Safety Profile of Biologic Drugs in the Treatment of Inflammatory Bowel Diseases: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.

scientific article published on 7 September 2016

Safety profile of biologic drugs in the therapy of Crohn disease: A systematic review and network meta-analysis

scientific article

Sipuleucel-T immunotherapy for castration-resistant prostate cancer. A systematic review and meta-analysis

scientific article

Systematic review of the effectiveness of biological therapy for active moderate to severe ulcerative colitis

scientific article

The European challenges of funding orphan medicinal products

scientific article

The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe

scientific article published on 06 September 2016

The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis

scientific article

The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis

scientific article

The impact of implemented regulations on biosimilars in Slovakia

scientific article published in December 2019

The indirect costs of ankylosing spondylitis: a systematic review and meta-analysis

scientific article published on 12 January 2015

The indirect costs of multiple sclerosis: systematic review and meta-analysis

scientific article published on 18 July 2015

The indirect costs of psoriatic arthritis: systematic review and meta-analysis

scientific article published on October 2014

The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

scientific article published on May 2014

Trends and determinants in reimbursement decision-making in Poland in the years 2013-2015.

scientific article published on 27 September 2017

Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis

scientific article

Vedolizumab Compared with Certolizumab in the Therapy of Crohn Disease: A Systematic Review and Indirect Comparison

scientific article

[Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review re

scientific article published on January 1, 2013

[The evaluation of cost-effectiveness and cost-utility of valganciclovir for the prophylaxis of cytomegalovirus disease to 200 days after kidney transplantation]

scientific article published in June 2013

Paulina is supported by:

About Paulina

Help